2017
DOI: 10.2967/jnumed.116.186874
|View full text |Cite
|
Sign up to set email alerts
|

CXCR4 Ligands: The Next Big Hit?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
80
0
3

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 128 publications
(88 citation statements)
references
References 87 publications
1
80
0
3
Order By: Relevance
“…Previous studies reported that SDF-1 was closely associated with angiogenesis and endothelial cell recruitment [35]. Therefore, EA.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies reported that SDF-1 was closely associated with angiogenesis and endothelial cell recruitment [35]. Therefore, EA.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, the SDF-1/CXCR4 signaling pathway is of vital importance in mesenchymal stem cell-induced osteogenic differentiation [33], and the upregulation of CXCR4 enhanced engraftment and bone mechanics in osteogenesis imperfecta [34]. Moreover, several studies suggested that SDF-1 is closely associated with angiogenesis, which is essential for osteogenesis [35]. Importantly, the downregulation of SDF-1 achieved by treatment with crude fucoidan extract lowered the vascularization in osteosarcoma [36].…”
Section: Introductionmentioning
confidence: 99%
“…Chia et al (2018) showed that, whilst CSF-1 played a role in macrophage recruitment, signalling to Cxcr4 was absolutely required for the recruitment of macrophages to the Akt-transformed brain in zebrafish tumour initiation, and that PNC-derived Cxcl12 was the major ligand for this interaction [142]. Cxcr4 signalling has been shown to promote progression of many cancers in mammals including glioblastoma, through both cancer cell autonomous signalling and leukocyte interactions [106,[176][177][178][179][180][181]. However, the pro-tumour effect of Cxcr4 signalling at the preneoplastic stage was macrophage specific [142].…”
Section: Chemokines Recruit Leukocytes To Pncsmentioning
confidence: 99%
“…[20] Several inhibitors or antagonists are already being evaluated in clinical PET and SPECT studies as imaging agents for the expression of the prostate-specific membrane antigen in prostate cancers, [21] the somatostatinr eceptor in neuroendocrine tumors, [22] and the chemokine receptor overexpressed in many types of human cancers. [23] Evidencef rom preclinical and clinical studies suggest that antagonists or inhibitors mayb es uperior to agonists, and are paving the way to as hift towards uch molecules as targeting agentsfor cancer imaging. [24] Our radiolabeling strategy involved at hree-component system constituted by the high affinity CFTR-specific targeting unit CFTR inh -172a, ar adiometal ( 99m Tc using the [ 99m Tc (CO) 3 ] + core), and ab ifunctional chelator (BFC),d esigned to bind to the radiometal and biomolecule.…”
Section: Introductionmentioning
confidence: 99%